Welcome to Satori OCS's comprehensive UK MHRA Regulatory, Registration, and Licensing Services. Our range of services is tailored to guide you through the intricacies of the UK Medicines and Healthcare products Regulatory Agency (MHRA) regulations, in ensuring compliance and successful market entry.
MHRA is the national regulatory authority for medicines, medical devices, and blood components in the United Kingdom. The MHRA is responsible for ensuring that all medicines and medical devices in the UK meet appropriate standards of safety, quality, and efficacy, and for monitoring their safety once they are on the market.
Responsible for granting licenses for drugs, medical devices, and healthcare products to ensure their safety and efficacy.
Conducts inspections to ensure compliance with MHRA regulations and takes necessary enforcement actions.
Monitors and assesses the safety of drugs and medical devices in the market, ensuring timely reporting of adverse events.
Our services expedite your MHRA compliance journey, ensuring timely market entry and ongoing success.
Choose Satori OCS as your reliable partner to guide you through the intricate UK MHRA regulatory landscape. Reach out to us today for a comprehensive consultation, and discover how our extensive expertise can effectively streamline your regulatory procedures, ensuring a seamless market entry and successful operations in the UK.
The duration of the MHRA drug approval process can vary based on factors such as the type of drug and regulatory review time. It typically ranges from several months to over a year.
Yes, UK regulatory consultants can assist pharmaceutical companies in the preparation and submission of applications for biosimilar approvals, which is a specialized area within the pharma industry.
Companies must establish post-market surveillance systems to monitor the safety and efficacy of their products and report adverse events in accordance with UK regulations.